201 related articles for article (PubMed ID: 24929209)
1. Alpha II Spectrin breakdown products in immature Sprague Dawley rat hippocampus and cortex after traumatic brain injury.
Schober ME; Requena DF; Davis LJ; Metzger RR; Bennett KS; Morita D; Niedzwecki C; Yang Z; Wang KK
Brain Res; 2014 Jul; 1574():105-12. PubMed ID: 24929209
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of non-erythroid alpha II-spectrin and calpain-cleaved alpha II-spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats.
Pike BR; Flint J; Dutta S; Johnson E; Wang KK; Hayes RL
J Neurochem; 2001 Sep; 78(6):1297-306. PubMed ID: 11579138
[TBL] [Abstract][Full Text] [Related]
3. Regional calpain and caspase-3 proteolysis of alpha-spectrin after traumatic brain injury.
Pike BR; Zhao X; Newcomb JK; Posmantur RM; Wang KK; Hayes RL
Neuroreport; 1998 Aug; 9(11):2437-42. PubMed ID: 9721910
[TBL] [Abstract][Full Text] [Related]
4. Degradation of βII-Spectrin Protein by Calpain-2 and Caspase-3 Under Neurotoxic and Traumatic Brain Injury Conditions.
Kobeissy FH; Liu MC; Yang Z; Zhang Z; Zheng W; Glushakova O; Mondello S; Anagli J; Hayes RL; Wang KK
Mol Neurobiol; 2015 Aug; 52(1):696-709. PubMed ID: 25270371
[TBL] [Abstract][Full Text] [Related]
5. Relationship of calpain-mediated proteolysis to the expression of axonal and synaptic plasticity markers following traumatic brain injury in mice.
Thompson SN; Gibson TR; Thompson BM; Deng Y; Hall ED
Exp Neurol; 2006 Sep; 201(1):253-65. PubMed ID: 16814284
[TBL] [Abstract][Full Text] [Related]
6. Dicyclomine, an M1 muscarinic antagonist, reduces biomarker levels, but not neuronal degeneration, in fluid percussion brain injury.
Cox CD; West EJ; Liu MC; Wang KK; Hayes RL; Lyeth BG
J Neurotrauma; 2008 Nov; 25(11):1355-65. PubMed ID: 19061379
[TBL] [Abstract][Full Text] [Related]
7. Alpha II-spectrin breakdown products serve as novel markers of brain injury severity in a canine model of hypothermic circulatory arrest.
Weiss ES; Wang KK; Allen JG; Blue ME; Nwakanma LU; Liu MC; Lange MS; Berrong J; Wilson MA; Gott VL; Troncoso JC; Hayes RL; Johnston MV; Baumgartner WA
Ann Thorac Surg; 2009 Aug; 88(2):543-50. PubMed ID: 19632410
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical study of calpain-mediated breakdown products to alpha-spectrin following controlled cortical impact injury in the rat.
Newcomb JK; Kampfl A; Posmantur RM; Zhao X; Pike BR; Liu SJ; Clifton GL; Hayes RL
J Neurotrauma; 1997 Jun; 14(6):369-83. PubMed ID: 9219852
[TBL] [Abstract][Full Text] [Related]
9. Spectrin breakdown products in the cerebrospinal fluid in severe head injury--preliminary observations.
Farkas O; Polgár B; Szekeres-Barthó J; Dóczi T; Povlishock JT; Büki A
Acta Neurochir (Wien); 2005 Aug; 147(8):855-61. PubMed ID: 15924207
[TBL] [Abstract][Full Text] [Related]
10. Alpha-II-spectrin after controlled cortical impact in the immature rat brain.
Aikman J; O'Steen B; Silver X; Torres R; Boslaugh S; Blackband S; Padgett K; Wang KK; Hayes R; Pineda J
Dev Neurosci; 2006; 28(4-5):457-65. PubMed ID: 16943668
[TBL] [Abstract][Full Text] [Related]
11. Detection of alphaII-spectrin and breakdown products in humans after severe traumatic brain injury.
Cardali S; Maugeri R
J Neurosurg Sci; 2006 Jun; 50(2):25-31. PubMed ID: 16841024
[TBL] [Abstract][Full Text] [Related]
12. Accumulation of calpain and caspase-3 proteolytic fragments of brain-derived alphaII-spectrin in cerebral spinal fluid after middle cerebral artery occlusion in rats.
Pike BR; Flint J; Dave JR; Lu XC; Wang KK; Tortella FC; Hayes RL
J Cereb Blood Flow Metab; 2004 Jan; 24(1):98-106. PubMed ID: 14688621
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of alphaII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury.
Pineda JA; Lewis SB; Valadka AB; Papa L; Hannay HJ; Heaton SC; Demery JA; Liu MC; Aikman JM; Akle V; Brophy GM; Tepas JJ; Wang KK; Robertson CS; Hayes RL
J Neurotrauma; 2007 Feb; 24(2):354-66. PubMed ID: 17375999
[TBL] [Abstract][Full Text] [Related]
14. Imaging and serum biomarkers reflecting the functional efficacy of extended erythropoietin treatment in rats following infantile traumatic brain injury.
Robinson S; Winer JL; Berkner J; Chan LA; Denson JL; Maxwell JR; Yang Y; Sillerud LO; Tasker RC; Meehan WP; Mannix R; Jantzie LL
J Neurosurg Pediatr; 2016 Jun; 17(6):739-55. PubMed ID: 26894518
[TBL] [Abstract][Full Text] [Related]
15. alphaII-Spectrin breakdown product cerebrospinal fluid exposure metrics suggest differences in cellular injury mechanisms after severe traumatic brain injury.
Brophy GM; Pineda JA; Papa L; Lewis SB; Valadka AB; Hannay HJ; Heaton SC; Demery JA; Liu MC; Tepas JJ; Gabrielli A; Robicsek S; Wang KK; Robertson CS; Hayes RL
J Neurotrauma; 2009 Apr; 26(4):471-9. PubMed ID: 19206997
[TBL] [Abstract][Full Text] [Related]
16. Temporal profile and cell subtype distribution of activated caspase-3 following experimental traumatic brain injury.
Beer R; Franz G; Srinivasan A; Hayes RL; Pike BR; Newcomb JK; Zhao X; Schmutzhard E; Poewe W; Kampfl A
J Neurochem; 2000 Sep; 75(3):1264-73. PubMed ID: 10936210
[TBL] [Abstract][Full Text] [Related]
17. Biochemical, structural, and biomarker evidence for calpain-mediated cytoskeletal change after diffuse brain injury uncomplicated by contusion.
McGinn MJ; Kelley BJ; Akinyi L; Oli MW; Liu MC; Hayes RL; Wang KK; Povlishock JT
J Neuropathol Exp Neurol; 2009 Mar; 68(3):241-9. PubMed ID: 19225412
[TBL] [Abstract][Full Text] [Related]
18. A calpain inhibitor attenuates cortical cytoskeletal protein loss after experimental traumatic brain injury in the rat.
Posmantur R; Kampfl A; Siman R; Liu J; Zhao X; Clifton GL; Hayes RL
Neuroscience; 1997 Apr; 77(3):875-88. PubMed ID: 9070759
[TBL] [Abstract][Full Text] [Related]
19. Calpain-mediated collapsin response mediator protein-1, -2, and -4 proteolysis after neurotoxic and traumatic brain injury.
Zhang Z; Ottens AK; Sadasivan S; Kobeissy FH; Fang T; Hayes RL; Wang KK
J Neurotrauma; 2007 Mar; 24(3):460-72. PubMed ID: 17402852
[TBL] [Abstract][Full Text] [Related]
20. A novel marker for traumatic brain injury: CSF alphaII-spectrin breakdown product levels.
Ringger NC; O'Steen BE; Brabham JG; Silver X; Pineda J; Wang KK; Hayes RL; Papa L
J Neurotrauma; 2004 Oct; 21(10):1443-56. PubMed ID: 15672634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
